Current management of NAFLD/NASH.

Area of Science:

• Hepatology
• Internal Medicine
• Public Health

Background:

• Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver condition globally.
• NAFLD prevalence is rapidly increasing worldwide.
• NAFLD is strongly associated with comorbidities like obesity, diabetes, and metabolic syndrome.

Purpose of the Study:

• To highlight the importance of early diagnosis and management of NAFLD.
• To emphasize the need to consider multiple etiologies in liver disease assessment.
• To outline current management strategies for NAFLD.

Main Methods:

• Review of existing studies on NAFLD prevalence and associations.
• Analysis of diagnostic considerations for liver disease.
• Summary of non-pharmacological treatment approaches for NAFLD.

Main Results:

• NAFLD is a significant and increasing cause of liver disease.
• Comorbidities like diabetes and obesity are common in NAFLD patients.
• No specific drug treatments are currently approved for NAFLD.

Conclusions:

• Early diagnosis and intervention are crucial for improving NAFLD prognosis.
• Comprehensive patient assessment should include evaluating multiple potential causes of liver disease.
• Lifestyle modifications, including diet and physical activity, are the cornerstone of NAFLD management.